Search through
Hero Background
rounded-bottom

Vildagliptin (CAS NO : 274901-16-5)

Vildagliptin is an orally active pharmaceutical ingredient used as a DPP-4 inhibitor for the management of type 2 diabetes mellitus. Vildagliptin or VILDAGLIPTIN [EMA EPAR] functions by increasing incretin levels, which regulate glucose homeostasis through enhanced insulin secretion and suppressed glucagon release. Vildagliptin has suitability for formulation development, clinical research, and pilot-scale API production. Also referred to as (LAF237, Vildagliptin Hydrochloride) by Vildagliptin manufacturers, characterised by high potency, oral bioavailability, and metabolic stability. We are the trusted Vildagliptin supplier worldwide, ensuring reliable lead times and consistent quality for pharmaceutical manufacturing and research.

Vildagliptin

Vildagliptin is an orally active pharmaceutical ingredient used as a DPP-4 inhibitor for the management of type 2 diabetes mellitus. Vildagliptin or VILDAGLIPTIN [EMA EPAR] functions by increasing incretin levels, which regulate glucose homeostasis through enhanced insulin secretion and suppressed glucagon release. Vildagliptin has suitability for formulation development, clinical research, and pilot-scale API production. Also referred to as (LAF237, Vildagliptin Hydrochloride) by Vildagliptin manufacturers, characterised by high potency, oral bioavailability, and metabolic stability. We are the trusted Vildagliptin supplier worldwide, ensuring reliable lead times and consistent quality for...

Get a Quote

Details included in quote

Minimum Order Quantity

Lead Time

Regional Availability

Incoterms

Rounded Top

Chemical Properties & Specifications

Applications of Vildagliptin

Pharmaceutical Use

Treatment of type 2 diabetes mellitus.

Mechanism of Action

DPP-4 inhibition increases incretin levels, enhancing insulin secretion.

Oral Bioavailability

High oral absorption allows flexible dosing.

Metabolic Stability

Resistant to rapid metabolism, enabling consistent therapeutic effects.

R & D

Preferred in preclinical and clinical research on DPP-4 inhibitors and glucose metabolism studies.

Have Questions About Vildagliptin?
We've Got Answers.

Suggested Products

No products found

Get a Quote

Get a Quote